science top stories popular news  

Daily non-political popular news in brief.

Botulism study could lead to new vaccines and treatments to counter bioterrorist attacks

12-13-2006 · EurekAlert!

Of all the weapons in the bioterrorist arsenal, none is as potent as botulinum neurotoxin, which causes botulism -- a potentially fatal disease with symptoms that include severe paralysis of the limbs and respiratory muscles. Of all the weapons in the bioterrorist arsenal, none is as potent as botulinum neurotoxin, which causes botulism -- a potentially fatal disease with symptoms that include severe paralysis of the limbs and respiratory muscles. Now, for the first time, scientists have figured out how this powerful neurotoxin disables individual nerve cells.

Read more »

Keywords: botulism, study, lead, vaccines, treatments, counter, bioterrorist, attacks, vaccine, treatment, attack

« Previous | Next »

Similar news on "Botulism study could lead to new vaccines and treatments to counter bioterrorist attacks":

  1. First genome-wide study of infectious disease opens new avenues for HIV treatment, vaccines
    07-19-2007 · EurekAlert!
    The first genome-wide association study of an infectious disease, conducted by an international group of researchers through the Center for HIV/AIDS Vaccine Immunology, has yielded a new understanding of why some people can suppress virus levels following HIV infection. "The clearer picture of host responses to the virus achieved through this examination of genomes could lead to improved HIV therapies and provides new targets for vaccine developers," says Elias A. Zerhouni, M.D., director of the National Institutes of Health.
    Similar news · Read more »
  2. Study analyzes heart attack mortality risk associated with Hodgkin disease treatments
    02-06-2007 · EurekAlert!
    Doctors have long known that patients treated for Hodgkin disease are at an increased risk for heart attacks. In the February 7 issue of the Journal of the National Cancer Institute, researchers quantify the risk of fatal heart attacks associated with different types of treatment, and they find that the increased risk persists for at least 25 years after Hodgkin disease treatment.
    Similar news · Read more »
  3. Active ingredient in common Chinese herb
    01-18-2007 · EurekAlert!
    Some 50 million Americans have hypertension, that is, blood pressure measuring above the normal range (less than 120/80 mmHg). If untreated, it can lead to heart attacks, strokes, or kidney disease. Lifestyle changes are the first-stage treatment for the disease, but if they fail, medications are prescribed. In a soon-to-be-released study using an animal model, scientists have found that tanshinone IIA, an active ingredient of danshen, reduces blood pressure.
    Similar news · Read more »
  4. Active ingredient in common Chinese herb shown to reduce hypertension
    01-18-2007 · EurekAlert!
    Some 50 million Americans have hypertension, that is, blood pressure measuring above the normal range (less than 120/80 mmHg). If untreated, it can lead to heart attacks, strokes, or kidney disease. Lifestyle changes are the first-stage treatment for the disease, but if they fail, medications are prescribed. In a soon-to-be-released study using an animal model, scientists have found that tanshinone IIA, an active ingredient of danshen, reduces blood pressure.
    Similar news · Read more »
  5. Increased hemodialysis may lead to greater survival rates
    11-06-2006 · EurekAlert!
    A study recently published in Hemodialysis International found that more frequent hemodialysis treatments (five or more weekly) can significantly increase the survival rate of patients suffering from irreversible kidney failure. Typical treatment in the US generally involves three sessions weekly.
    Similar news · Read more »
  6. Temple University Hospital investigates new prophylactic HPV vaccine
    01-30-2007 · EurekAlert!
    Temple University Hospital's Center For Women's Health is participating in a national study to determine the safety and effectiveness of an investigational treatment for cervical dysplasia. According to the American Cancer Society, approximately 500,000 women are diagnosed with high-grade cervical dysplasia each year, with roughly 10,000 cases progressing to cervical cancer.The expected widespread availability of two preventive vaccines may lower the incidence of HPV infection and reduce the risk of cervical cancer.
    Similar news · Read more »
  7. First human trial tests stem-cell-based treatment for heart attacks
    03-25-2007 · EurekAlert!
    Previous research on the efficacy of stem cell therapy for heart repair has shown possible benefit from mesenchymal stem cells (MSCs) -- cells found in bone marrow that create connective tissue, bone and cartilage. A study presented today at the American College of Cardiology's Innovation in Intervention: i2 Summit reveals the results of the first human trial using MSCs for the treatment of myocardial infarction (MI, or heart attack).
    Similar news · Read more »
  8. System to analyze beating heart stem cells could lead to heart attack treatments
    07-29-2007 · EurekAlert!
    New research at the University of Nottingham, funded by the Biotechnology and Biological Sciences Research Council, is paving the way for techniques that use stem cells to repair the damage caused by heart attacks.
    Similar news · Read more »
  9. New treatments have major impact on heart failure rates
    05-01-2007 · EurekAlert!
    Deaths from severe heart attacks following admission to hospital have nearly halved in six years as a result of advances in medical treatment.In the largest study of its kind, research led by the University of Edinburgh, analyzed hospital treatment and outcomes for 44,372 patients admitted to 113 hospitals in 14 countries with heart attacks or unstable angina (threatened heart attacks).
    Similar news · Read more »
  10. Protein a possible key to allergy and asthma control
    01-02-2008 · EurekAlert!
    Activating a protein found on some immune cells seems to halt the cells' typical job of spewing out substances that launch allergic reactions, a study by Johns Hopkins researchers suggests. The findings could eventually lead to new treatments for allergic reactions ranging from annoying bouts of hay fever to deadly asthma attacks.
    Similar news · Read more »